BMX-IN-1 - CAS# 1431525-23-3 0268 Fmk is an irreversible ribosomal

Fmk is an irreversible ribosomal S6 kinase inhibitor 1/2 inhibitor

InChiKey: FBLPQCAQRNSVHB-UHFFFAOYSA-N

8aS)-7-amino-6-{[(1R

InChiKey: GYLDXIAOMVERTK-UHFFFAOYSA-N

once-daily oral NS5A inhibitor for the treatment of hepatitis C virus infection

BMX-IN-1 - CAS# 1431525-23-3 0268 Fmk is an irreversible ribosomalBMX IN 1 is a selective irreversible BMX inhibitor for prostate cancer. BMX IN 1 can covalently modifies Cys496. BMX IN 1 inhibits the proliferation of Tel BMX transformed Ba F3 cells at two digit nanomolar concentrations but requires single digit micromolar concentrations to inhibit the proliferation of prostate cancer cell lines. MK2206, is able to potentiate BMX inhibitor's antiproliferation efficacy against prostate cancer cells. Product